Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO - Euronext Amsterdam - NL0012059018 - Common Stock - Currency: EUR

82.45  -0.15 (-0.18%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EXO. EXO was compared to 51 industry peers in the Financial Services industry. While EXO seems to be doing ok healthwise, there are quite some concerns on its profitability. EXO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year EXO was profitable.
EXO had a positive operating cash flow in the past year.
Of the past 5 years EXO 4 years were profitable.
In the past 5 years EXO always reported a positive cash flow from operatings.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

The Return On Assets of EXO (34.55%) is better than 98.04% of its industry peers.
Looking at the Return On Equity, with a value of 38.39%, EXO belongs to the top of the industry, outperforming 86.27% of the companies in the same industry.
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

EXO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

4

2. Health

2.1 Basic Checks

EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EXO has less shares outstanding
The number of shares outstanding for EXO has been reduced compared to 5 years ago.
The debt/assets ratio for EXO has been reduced compared to a year ago.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

An Altman-Z score of 3.78 indicates that EXO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.78, EXO is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
EXO has a debt to FCF ratio of 87.02. This is a negative value and a sign of low solvency as EXO would need 87.02 years to pay back of all of its debts.
EXO has a worse Debt to FCF ratio (87.02) than 72.55% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that EXO is not too dependend on debt financing.
EXO has a better Debt to Equity ratio (0.08) than 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Altman-Z 3.78
ROIC/WACCN/A
WACC7.13%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
The Current ratio of EXO (0.19) is worse than 74.51% of its industry peers.
EXO has a Quick Ratio of 0.19. This is a bad value and indicates that EXO is not financially healthy enough and could expect problems in meeting its short term obligations.
EXO has a worse Quick ratio (0.19) than 74.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

2

3. Growth

3.1 Past

EXO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 262.89%, which is quite impressive.
Measured over the past years, EXO shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.47% on average per year.
The Revenue for EXO has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, EXO will show a very negative growth in Earnings Per Share. The EPS will decrease by -49.89% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.23, the valuation of EXO can be described as very cheap.
EXO's Price/Earnings ratio is rather cheap when compared to the industry. EXO is cheaper than 94.12% of the companies in the same industry.
EXO is valuated cheaply when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.59, the valuation of EXO can be described as very reasonable.
Based on the Price/Forward Earnings ratio, EXO is valued a bit cheaper than 68.63% of the companies in the same industry.
EXO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 1.23
Fwd PE 10.59
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

EXO's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. EXO is more expensive than 72.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 387.66
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

A cheap valuation may be justified as EXO's earnings are expected to decrease with -49.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.56%, EXO is not a good candidate for dividend investing.
EXO's Dividend Yield is comparable with the industry average which is at 3.88.
With a Dividend Yield of 0.56, EXO pays less dividend than the S&P500 average, which is at 2.51.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years1
Div Non Decr Years1
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

0.67% of the earnings are spent on dividend by EXO. This is a low number and sustainable payout ratio.
The Dividend Rate of EXO has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0.67%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
EXO.AS Dividend Payout.EXO.AS Dividend Payout, showing the Payout Ratio.EXO.AS Dividend Payout.PayoutRetained Earnings

More info and screens

EXOR NV

AMS:EXO (4/25/2025, 7:00:00 PM)

82.45

-0.15 (-0.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-17 2025-09-17
Inst Owners27.54%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap18.22B
Analysts85
Price Target120.36 (45.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP0.67%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.61%
PT rev (3m)0.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.37%
EPS NY rev (3m)-13.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.23
Fwd PE 10.59
P/S N/A
P/FCF 387.66
P/OCF 387.66
P/B 0.48
P/tB 0.48
EV/EBITDA N/A
EPS(TTM)66.88
EY81.12%
EPS(NY)7.79
Fwd EY9.44%
FCF(TTM)0.21
FCFY0.26%
OCF(TTM)0.21
OCFY0.26%
SpS0
BVpS172.92
TBVpS172.92
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 0.32%
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 3.78
F-Score5
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.63%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-99.25%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%